Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion.
Mataix. Manuel M; Illera. Nuria N; Hidalgo. Inés I; Arriba. Maria Del Carmen de MDC; Martín. Elena E; Fernández. Gerónimo G; González. Carlos C; Larcher. Fernando F; González. Victor M VM; Rio. Marcela Del MD; Jiménez. Francisco F; Carretero. Marta M
Key Findings
- A DNA aptamer (Ap.OR2AT4.17) specifically activates the OR2AT4 receptor in human hair follicles.
- Aptamer treatment prolongs the anagen (growth) phase, increases matrix keratinocyte proliferation, and elongates hair shafts in organ culture.
- Treatment upregulates antimicrobial peptides LL‑37 and β‑defensin‑3, indicating potential microbiota‑modulating effects.
Practical Outcomes
- The study shows a promising new way to stimulate hair growth by targeting OR2AT4, but it’s still at the lab‑culture stage and not ready for consumer use. For biohackers, the main takeaway is that future topical or systemic products might emerge from this approach, potentially offering a more targeted alternative to existing hair‑loss treatments. Keep an eye on follow‑up studies for safety, dosing, and real‑world efficacy before considering any DIY applications.
Summary
Scientists found a DNA aptamer that can stick to a skin receptor called OR2AT4 and keep hair follicles in the growth phase longer. In lab-grown human hair follicles, this aptamer boosted the receptor, made hair‑producing cells multiply, and grew longer hair shafts. It also raised levels of the antimicrobial peptide LL‑37, suggesting it might affect skin microbes too.
Abstract
Non-canonical functions of olfactory receptors, one of the largest families of GPCR receptors not confined to the olfactory system, include an intriguing role on hair physiology. Previous studies using odorant agonists of the Olfactory Receptor family 2 subfamily AT member 4 (OR2AT4) showed hair growth stimulation. To develop more effective topical or systemic treatments for hair growth by specifically activating this receptor, it is crucial to identify new molecules with potent and well-defined activity. Here, we present a significant advancement in targeted therapeutic strategies for hair loss through the identification of a highly specific DNA aptamer targeting OR2AT4. The selected aptamer, designed as Ap.OR2AT4.17, effectively prolonged the anagen phase of hair growth cycle in a valuable preclinical human organ culture model. Importantly, the identified OR2AT4 aptamer was shown to be functional, leading to enhanced OR2AT4 expression in hair follicles, increased proliferation of hair matrix keratinocytes, and significant hair shaft elongation in organ-cultured human hair follicles. Notably, aptamer treatment also upregulated LL-37 and human β defensin-3 antimicrobial peptide expression, highlighting its role as a microbiota-modulating compound. These findings underscore the OR2AT4 aptamer's potential as a novel, targeted therapy for hair loss disorders, marking a promising step forward in the field.
Study Information
pubmed
2025
2025-06-16T00:00:00.000Z
10.1016/j.omtn.2025.102608